Analyst Gives Strong Buy Recommendation for OREX Pharmaceutical Stock

July 12, 2010 - PRLog -- The STW stock analysis and recommendation of the week is OREX an emerging biotech - pharmaceutical company. They are one of  3 companies developing obesity – weight loss drugs awaiting FDA approval. For specific details about OREX stock visit http://www.stocktipweekly.com  where stock market investors and swing traders benefit from the research and experience of the STW analysts. Always do your own their own due diligence before taking a position in OREX or any other investment.

ABOUT
The stock analysts at STW isolate emerging & small cap stocks focusing on the biotech and pharmaceutical sectors. Each week they feature one stock recommendation that analysis shows has good upside potential for a swing trade or long term profits. The STW Stock Picks are chosen on several factors including current company news, FDA trials, technical analysis and general market trends to help traders and investors select the best share price entry and timing.